“How long will treatment in China take?” is the question families ask most often and the hardest to answer in one sentence. The answer depends on three things: whether the diagnosis is already clear, whether the plan needs adjusting during surgery, and how long the visa permits you to stay.
This article breaks the usual 21–45 days into four stages, with a day-by-day table. All the day counts are process references, not a promise about the length of treatment in any individual case; what applies in practice is the receiving hospital’s schedule and the physician’s judgement.
On what the window covers: the 21–45 days refers to the length of stay in China (arrival, diagnosis, treatment, discharge and the journey home). Pre-departure preparation usually takes about another 2 weeks, and it is the two together that make up the full span from deciding to go to China to arriving back in Malaysia.
1. The four-stage structure
| Stage | Reference days | Objective | Main party responsible |
|---|---|---|---|
| A. Pre-departure preparation | Within the 2 weeks before departure (from D-14) | Documents complete, visa in hand, bed and outpatient schedule confirmed | Family + platform + hospital |
| B. Arrival and diagnosis | Days 1–3 | Consultation, supplementary tests, plan confirmation and informed consent | Mainly the hospital |
| C. Treatment and observation | Days 4–30 | Delivering treatment, assessing response, managing complications | Mainly the hospital |
| D. Discharge and return to Malaysia | Days 30–45 | Discharge settlement, completing the file, connecting the journey home with follow-up | Family + platform |
Stage C and stage D meet around Day 30: inpatient treatment usually comes to an end around Day 30, and stage D covers discharge settlement and the journey home. In practice the two overlap by a few days and are not a strict division.
2. Day-by-day timeline
| Time point | Item | Who does it | Output / evidence |
|---|---|---|---|
| D-14 to D-8 | Submit the complete medical record and apply for a second opinion and admission assessment | Family + platform | Written opinion, judgement on admission feasibility |
| D-7 | The hospital issues the medical invitation letter; visa documents are prepared | Platform + hospital international office | Invitation letter, visa application documents |
| D-6 to D-4 | Submit the S2 application or confirm visa-free entry arrangements | Family | Visa or entry plan |
| D-3 | Book flights and accommodation, confirm airport pickup | Family + platform | Itinerary |
| D-1 | Back up copies of the documents; carry prescriptions and medication with you | Family | Copy of the medical record + medication list |
| Day D | Arrive, settle in, meet the accompanying coordinator | Platform | Hospital arrival time and contact person |
| D+1 | Outpatient consultation; supplementary tests ordered | Hospital | Outpatient record, test requests |
| D+2 to D+3 | Necessary tests completed, multidisciplinary team meeting (MDT), plan confirmed | Hospital | Consultation opinion, informed consent form |
| D+3 to D+5 | Pay, complete admission formalities, pre-operative preparation | Family + hospital | Deposit receipt, admission certificate |
| Treatment period | Surgery / radiotherapy and chemotherapy / targeted or cell therapy | Hospital | Treatment records, medication records |
| Mid-treatment | Assessment of response and adverse reactions; plan adjusted if necessary | Hospital | Review reports |
| 1–2 days before discharge | Request the entire discharge file in one go | Family (through the international medical department) | Discharge summary, itemised bill, corporate receipts |
| Discharge day | Settlement, collecting medication and discharge medication instructions, booking the follow-up appointment | Family + hospital | Discharge instructions, prescription |
| 1–3 days after discharge | Return to Malaysia (on a travel date permitted by the physician) | Family | — |
| Within 7 days of returning to Malaysia | Hand over the documents to the local treating physician and arrange the review | Family + local physician | Handover record |
| Within 30 days of returning to Malaysia | Submit the insurance claim, coordinate follow-up and prescription renewal | Family + platform | Claim file |
On the timing of the S2 visa: the S2 medical visa usually takes longer than 3 days to process. D-6 to D-4 in the table above is the submission point; when the visa is issued depends on the processing progress of the embassy or consulate. If the S2 is definitely needed, apply as soon as the documents are complete and do not leave submission to within the last week before departure.
3. Length of stay in China by treatment modality (reference)
The timeline calculator on this site’s journal page uses exactly this set of figures: the numbers are taken from the national-standard wording for each modality and are not independently estimated.
| Treatment modality | Reference length of stay in China | Notes |
|---|---|---|
| Written second opinion review | No travel to China required, about 48 hours | No attendance at any point; a written opinion is issued |
| Prescribing and assessment for a new targeted drug | About 7–10 days | Consultation + necessary tests + first dose and observation |
| Minimally invasive and complex surgery for difficult tumours | About 14–21 days | Pre-operative assessment, surgery, post-operative observation and suture removal |
| Proton and heavy ion precision radiotherapy | About 25–35 days | Fractionated irradiation, usually scheduled week by week |
| CAR-T cell manufacturing and reinfusion | About 28–45 days | Collection, manufacturing, lymphodepletion, reinfusion and the observation period |
For the same modality, the differences between patients come mainly from three places: the number of supplementary tests, how long complications take to manage, and how tightly the hospital can schedule. Any claim offering a “fixed XX days” should not be believed.
4. How the permitted stay matches the visa
The permitted stay must cover the treatment period and allow a buffer; otherwise an extension is needed part-way through, which affects both the itinerary and the cost.
| Situation | Stay arrangement | Suitable treatments | Points to note |
|---|---|---|---|
| China–Malaysia mutual visa exemption (single stay of ≤30 days) | Visa-free entry | Consultations, second opinions arranged in person, short test courses, 7–10 day targeted drug prescribing | The 30 days are calendar days, and a buffer is needed for possible delays |
| S2 medical companion visa | The permitted stay is issued by the issuing authority case by case | Long-cycle treatment such as surgery, radiotherapy and cell therapy | Requires the hospital’s medical invitation letter and related documents |
| Accompanying family members | Depends on the visa type | — | Companion documents are more straightforward for immediate family; other relatives need separate arrangements |
Visa categories and documents are governed by the current requirements of the Chinese embassy and consulates in Malaysia and the Chinese Visa Application Service Center in Kuala Lumpur; a separate article on this site, /visa-s2/, explains this in detail. Do not use visa-free entry for treatment that needs more than a month of observation — arranging an extension part-way through is far more troublesome than obtaining the visa in advance.
5. Five variables that tend to drag the timeline out
| Variable | Effect | How to deal with it in advance |
|---|---|---|
| Pathology requires additional immunohistochemistry or genomic testing | Delays by 3–10 days | Confirm the pathology slide numbers and the detected loci before departure |
| Imaging is not raw DICOM data | Must be re-exported, delaying by 2–5 days | Have the disc exported at the local imaging centre before departure |
| Scheduling of the multidisciplinary meeting | Usually held at fixed times a few days each week | Submit the consultation request on the first day after arrival |
| Chinese public holidays and weekends | Scheduling and discharge settlement are pushed back | Avoid the long-holiday windows when scheduling |
| Border policy and flight changes | Affect the journey itself | Allow a 2–3 day buffer and do not schedule to the limit |
6. Returning to Malaysia is not the end
The handover in the 30 days after treatment ends often decides whether prescription renewal, review and claims go smoothly afterwards:
- Document handover: give the discharge summary, imaging and medication list to the local treating physician to form a local follow-up file.
- Prescription renewal and medication: for long-term medication such as targeted drugs, local availability and the renewal pathway must be confirmed in advance; see /susulan-rawatan/.
- Compliance for bringing medication in: discharge medication involves China’s exit declaration and Malaysia’s entry rules, and is explained separately in /artikel/discharge-medication-customs-npra/.
- Claims: submit as soon as the discharge file is complete; the checklist is in /artikel/insurance-takaful-claim-documents/.
7. Frequently asked questions
Q: Can I enter visa-free first and decide about treatment later?
You can, but you must either complete treatment within the visa-free period or obtain an extension. If the assessment confirms that long-cycle treatment is needed, it is advisable to apply inside China for the appropriate permit to stay in accordance with the law, or to follow the process at /hantar-kes/ and obtain the visa before setting off.
Q: Must a family member accompany the patient throughout?
Not necessarily, but at least one family member is recommended to be in the country during the inpatient period. Informed consent, payment and discharge settlement on the hospital side all require someone to sign or attend in person.
Q: If treatment goes better than expected, can we return home early?
Yes, but the treating physician must agree and issue discharge instructions. Early discharge does not affect later follow-up, but the return flights and the continuity of medication need attention.
Q: Which step of the whole process goes wrong most easily?
Pre-departure documents. The great majority of delays do not happen during the treatment stage but at the pre-departure details such as “pathology needs more material” and “imaging has to be re-exported”.
This column explains the process and compliance points. It does not constitute medical advice. The specific duration of treatment, the plan and the schedule are determined independently by the treating physician team of the receiving hospital on the basis of in-person findings.
Reference sources
- Embassy of the People’s Republic of China in Malaysia: the China-Malaysia mutual visa exemption agreement takes effect on 17 July 2025: https://my.china-embassy.gov.cn/fwzc/lsyw/zytz/qzxgtz/202507/t20250714_11670211.htm
- Embassy of the People’s Republic of China in Malaysia: FAQ on the China-Malaysia mutual visa exemption agreement: https://my.china-embassy.gov.cn/fwzc/lsyw/lszj/fhqz2024/cjwdvisa/202508/t20250801_11681383.htm
- Embassy of the People’s Republic of China in Malaysia: introduction to Chinese visas (S1 / S2 categories): https://my.china-embassy.gov.cn/fwzc/lsyw/lszj/fhqz2024/fhqzjj/202402/t20240207_11242370.htm
- Chinese Visa Application Service Center in Kuala Lumpur, CVASC (visa categories and document requirements): https://www.visaforchina.cn/KUL3_EN/
- National Health Commission of China (medical institutions and clinical technology management): https://en.nhc.gov.cn/
- Ministry of Health Malaysia, MOH (local referral and medical institution information): https://www.moh.gov.my/